foxo4-dri senolytic peptide human trial Peptide Inhibitors Targeting FOXO4-p53 Interactions – FOXO4-DRI Peptide - Nationwide Peptides

GHK-Cu works by stimulating collagen synthesis, accelerating tissue repair, reducing inflammation, and improving overall skin integrity

Combined, the peptides accelerate every phase of healing reducing excess inflammation, enhancing tissue growth, and supporting proper remodeling

Peptide Sequence (IUPAC Condensed): H-Tyr-Leu-Arg-Ile-Val-Gln-Cys(1)-Arg-Ser-Val-Glu-Gly-Ser-Cys(1)-Gly-Phe-OH Molecular Formula: C78H123N23O23S2 Molecular Weight: 1815.1 g/mol Synonyms: Anti-Obesity Drug 9604 View the AOD-9604 Certificate Of Analysis (COA) View the AOD-9604 High Performance Liquid Chromatography (HPLC) AOD-9604 works by targeting beta-3 adrenergic receptors, which are mostly found in fat tissue

This is mainly due to the absence of chemicals such as benzyl alcohol in sterile solution

Retatrutide may have an edge for visceral fat reduction given the glucagon component effects on liver fat metabolism